Visit-to-visit variability and seasonal variation in blood pressure: Combination of antihypertensive therapy in the elderly, multicenter investigation (CAMUI) Trial subanalysis

Clinical and Experimental Hypertension

Volumn 37, Issue 5, 2015, Pages 411-419

  Sato, Nobuyuki ^a   Saijo, Yasuaki ^a   Sasagawa, Yutaka ^b   Morimoto, Hideo ^c   Takeuchi, Toshiharu ^a   Sano, Hiroaki ^d   Koyama, Satoshi ^e   Takehara, Naofumi ^a   Morita, Kazutoyo ^f   Sumitomo, Kazuhiro ^a   Maruyama, Junichi ^e   Kikuchi, Kenjiro ^g   Hasebe, Naoyuki ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b Rumoi Municipal Hospital   (Japan)

^c Department of Pediatrics Fukagawa Municipal Hospital   (Japan)

^d National Hospital Organization   (Japan)

^e Asahikawa Rehabilitation Hospital   (Japan)

^f Shibetsu City Hospital   (Japan)

^g Hokkaido Cardiovascular Hospital   (Japan)

Author keywords

Antihypertensive agents; Blood pressure variability; Combination therapy; Hypertension; Renal outcome

Indexed keywords

ALBUMIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CREATININE; HYDROCHLOROTHIAZIDE PLUS LOSARTAN; LOSARTAN; OLMESARTAN; TELMISARTAN; VALSARTAN; HYDROCHLOROTHIAZIDE;

ADD ON THERAPY; AGED; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BLOOD PRESSURE VARIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DRUG WITHDRAWAL; ENVIRONMENTAL TEMPERATURE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OPEN STUDY; ORTHOSTATIC HYPOTENSION; OUTPATIENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEASONAL VARIATION; SUMMER; SYSTOLIC BLOOD PRESSURE; WINTER; BLOOD PRESSURE; CLINICAL TRIAL; COMBINATION DRUG THERAPY; DRUG EFFECTS; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; SEASON; TREATMENT OUTCOME;

AGED; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; LOSARTAN; MALE; PROSPECTIVE STUDIES; SEASONS; TREATMENT OUTCOME;

EID: 84944037120     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2014.995802     Document Type: Conference Paper

References (31)

1. Ogihara T, Kikuchi K, Matsuoka H, et al. Japanese Society of Hypertension Committee. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009;32:3-107.
2. Shimamoto K, Ando K, Fujita T, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res. 2014;37:253-387.
3. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;34: 2159-219.
4. James PA, Oparil S, Carter BL, et al. Evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507-20 (Erratum in: JAMA 2014;311:1809).
5. McManus RJ, Caulfield M, Williams B; National Institute for Health and Clinical Excellence. NICE hypertension guideline 2011: Evidence based evolution. BMJ 2012;344:e181.
6. Sato N, Saijo Y, Sasagawa Y, et al; CAMUI Investigators. Combination of antihypertensive therapy in the elderly, multicenter investigation (CAMUI) trial: Results after 1 year. J Hypertens 2013; 31:1245-55.
7. Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010;375: 895-905.
8. Kikuya M, Ohkubo T, Metoki H, et al. Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: The Ohasama study. Hypertension 2008;52:1045-50.
9. Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: A systematic review and meta-analysis. Lancet 2010;375:906-15.
10. Matsui Y, O'Rourke MF, Hoshide S, et al. Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: The Japan Combined Treatment With Olmesartan and a Calcium- Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study. Hypertension 2012;59:1132-8.
11. Sega R, Cesana G, Bombelli M, et al. Seasonal variations in home and ambulatory blood pressure in the PAMELA population. Pressione Arteriose Monitorate E Loro Associazioni. J Hypertens 1998;16:1585-92.
12. Modesti PA, Morabito M, Bertolozzi I, et al. Weather-related changes in 24-hour blood pressure profile: Effects of age and implications for hypertension management. Hypertension 2006;47: 155-61.
13. Sato N, Saijo Y, Hasebe N; CAMUI Investigators. Combination of Antihypertensive Therapy in the Elderly, Multicenter Investigation (CAMUI) trial: Rationale and design. Int Heart J 2012;53:244-8.
14. Matsuo S, Imai E, Horio M, et al.; Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009;53:982-92.
15. Jamerson K, Weber MA, Bakris GL, et al; ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008;359: 2417-28.
16. Bakris GL, Sarafidis PA, Weir MR, et al; ACCOMPLISH Trial Investigators. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): A prespecified secondary analysis of a randomised controlled trial. Lancet 2010;375: 1173-81.
17. Bakris GL, Toto RD, McCullough PA, et al; GUARD (Gauging Albuminuria Reduction With Lotrel in Diabetic Patients With Hypertension) Study Investigators. Effects of different ACE inhibitor combinations on albuminuria: Results of the GUARD study. Kidney Int 2008;73:1303-9.
18. Loutzenhiser RD, Epstein M, Fischetti F, Horton C. Effects of amlodipine on renal hemodynamics. Am J Cardiol 1989;64: 1221-71; discussion 127I-8I.
19. Hayashi K, Ozawa Y, Fujiwara K, et al. Role of actions of calcium antagonists on efferent arteries-with special references to glomerular hypertension. Am J Nephrol 2003;23:229-44.
20. Iino Y, Hayashi M, Kawamura T, et al; Japanese Losartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) Study Investigators. Renoprotective effect of losartan in comparison to amlodipine in patients with chronic kidney disease and hypertension-a report of the Japanese Losartan Therapy Intended for the Global Renal Protection in Hypertensive (JLIGHT) study. Hypertens Res 2004;27:21-30.
21. Puig JG, Marre M, Kokot F, et al. Efficacy of indapamide SR compared with enalapril in elderly hypertensive patients with type 2 diabetes. Am J Hypertens 2007;20:90-7.
22. Okada H, Fukui M, Tanaka M, et al. Visit-to-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetes. Atherosclerosis 2012;220:155-9.
23. Noshad S, Mousavizadeh M, Mozafari M, et al. Visit-to-visit blood pressure variability is related to albuminuria variability and progression in patients with type 2 diabetes. J Hum Hypertens 2014;28:37-43.
24. Yokota K, Fukuda M, Matsui Y, et al. Impact of visit-to-visit variability of blood pressure on deterioration of renal function in patients with non-diabetic chronic kidney disease. Hypertens Res 2013;36:151-7.
25. Hoshide S, Yano Y, Shimizu M, et al. Is home blood pressure variability itself an interventional target beyond lowering mean home blood pressure during anti-hypertensive treatment? Hypertension Res 2012;35:862-6.
26. Brook RD, Weder AB, Rajagopalan S. "Environmental hypertensionology" the effects of environmental factors on blood pressure in clinical practice and research. J Clin Hypertens (Greenwich) 2011;13:836-42.
27. Modesti PA, Morabito M, Massetti L, et al. Seasonal blood pressure changes: An independent relationship with temperature and daylight hours. Hypertension 2013;61:908-14.
28. Wada Y, Hamamoto Y, Ikeda H, et al. Seasonal variations of urinary albumin creatinine ratio in Japanese subjects with type 2 diabetes and early nephropathy. Diabet Med 2012;29:506-8.
29. Masugata H, Senda S, Inukai M, et al. Seasonal variation in estimated glomerular filtration rate based on serum creatinine levels in hypertensive patients. Tohoku J Exp Med 2011;224: 137-42.
30. Arjamaa O, Turunen L, Mäkinen T, et al. Blood pressure and hormonal responses to short whole body cold exposure in subjects with high dietary salt intake. Appl Human Sci 1999;18: 203-9.
31. Yilmaz R, Akoglu H, Altun B, et al. Dietary salt intake is related to inflammation and albuminuria in primary hypertensive patients. Eur J Clin Nutr 2012;66:1214-18.